Automated and Easily Scalable Swab-Based Workflow Supports Increased Sample Throughput and Processing Consistency

WALTHAM, Mass. & WATERTOWN, Mass., May 26, 2022--(BUSINESS WIRE)--Rhinostics Inc. and Nexus Medical Labs recently received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for a molecular SARS-CoV-2 test enabling unsupervised self-collection. The test, based on a workflow originally developed by Harvard University, relies on high throughput lab automation and use of the RHINOstic™ Automated Nasal Swab from Rhinostics.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220526005202/en/

The patent-pending RHINOstic™ Automated Swab collection device integrates a unique swab head design with an active cap that works with decapping robotics for hands-free sample processing from accessioning, decapping, elution, and preparation of the assay plate for polymerase chain reaction (PCR), next-generation sequencing (NGS), or protein-based testing workflows. This automation-friendly design enables walkaway processing to save time, conserve labor, and boost quality of results compared to manual processing methods. (Photo: Business Wire)

"This EUA approval is an acknowledgment that we have developed and validated a high quality, cost-effective and rapid turnaround test. Our clients are now able to offer ultra-rapid and high-quality testing services that translates into same-day and reliable service at a better value," said Rob Miller, Co-Founder and CEO at Nexus.

Nexus specializes in offering improved access to laboratory testing to telehealth, partner laboratories, and other clients, processing medically and self-collected samples in its CLIA-certified laboratory. The facility has been outfitted with the automated RHINOstic™ swab workflow to process COVID-19 and other swab-based tests, with capacity that can scale to tens of thousands per day. High throughput processing facilitates turnaround times as low as 4 hours.

"We look forward to expanding our offering to a broad array of telehealth providers, partner laboratories, companies, schools, and associations that seek to ensure the health of their respective legions. Making affordable quality lab testing more accessible is a core part of our mission," says Brandon Johnson, Co-Founder and Managing Director at Nexus.

"Nexus’ EUA authorization further validates the clinical utility of our novel automated nasal swabs, where they have been shown to drop labor costs by 90% in addition to the benefits of robotics in terms of removing errors and bringing more repeatability to the workflow. We are excited to continue to work together on our next applications, which include genomic testing and sexually transmitted diseases with our swabs," noted Cheri Walker, PhD, President and CEO of Rhinostics. "As the telehealth market continues to rapidly expand, providers can depend on Nexus and automated RHINOstic™ workflows to deliver high-quality and cost-effective results."

The patent-pending and U.S. FDA Class I exempt RHINOstic Automated Nasal Swab collection device integrates a unique swab head design with an automated cap. This automation-friendly design enables walkaway processing to save time, conserve labor, and boost quality of results compared to manual processing methods.

Nexus Medical Laboratories aims to bring the next generation of diagnostics and sample collection tools directly into the hands of patients everywhere. A new lab launched in 2021 by industry leaders in diagnostics, home collected samples, and COVID-19 testing, Nexus is implementing cutting edge laboratory automation technologies that allow the highest quality of service levels with the fastest turnaround times. Nexus team members have successfully worked with the largest and most reputable labs in the world, produced multiple products in the diagnostics disposables space at over 100 million units per year at less than 10c per unit, created the first home blood collection device to match laboratory collection standards of accuracy, and established a COVID testing lab with capacity for more than 20,000 samples per day.

To learn more, visit http://nexusmedlabs.com.

Rhinostics is at the forefront of revolutionizing sample collection, a spin-out company from Harvard University and Wyss Institute, that is taking a radical new approach to sample collection device design and function. We recognize that many automated microplate-based workflows are encumbered by manual steps at the workflow’s beginning, and aim to develop and commercialize elegant, automated collection devices to break through these bottlenecks. Using our advanced collection device technologies such as the RHINOstic™ Automated Nasal Swab, test kit manufacturers can empower comfortable yet high-end patient experiences with abundant and clean sample yields for tests from lateral flow to microfluidics; all while boosting profits and differentiating their brand. Test processing laboratories conducting sensitive assays from traditional PCR to LAMP or antigen testing and more gain 10x sample throughput compared to manual workflows for cost-effective and robust assay performance even when working with difficult samples; with labor reductions of 80+%, even during times of surging demand. Rhinostics aids testing workflows during the COVID-19 pandemic and beyond – in areas like respiratory disease, genomics, STDs, forensic and much more. Rhinostics products are registered as Class I exempt medical devices with the U.S. FDA and may be used for clinical collection upon CLIA validation. In 2022, Rhinostics received a Bronze Edison Award in the COVID-19 Innovations, Testing Solutions category for the RHINOstic Automated Nasal Swab. To learn more, visit https://www.rhinostics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220526005202/en/

Media Contact: Chere Griffin, Rhinostics Inc. 978-793-7865 chere_griffin@rhinostics.com

Investor Contact: Cheri Walker, Rhinostics Inc. info@rhinostics.com

When GSK spins off its consumer health division in July, it will become one of the last drug conglomerates to shed its sideline businesses to focus on biotech-style medicines. The shift has big implications for investors—and overall public health.

Yahoo Finance health care correspondent Anjalee Khemlani joins the Live show to discuss Florida being the only state not to order Pfizer and Moderna's FDA approved COVID vaccines for children 5-years old and under.

More than half of U.S. adults have gone into debt because of medical and dental bills in the last five years, a poll found. In partnership with Kaiser Health News, Anna Werner takes a look at the devastating toll medical debt is taking on families.

Florida is the only state not to pre order vaccines for children under 5.

The Fed's 75 basis point rate hike comes after a hotter-than-expected inflation report on May consumer prices.

The cryptocurrency market’s latest swoon has raised the specter of bankruptcy restructuring. In such a case, crypto investors would be navigating uncharted territory.

Alicia Munnell, head of the Boston College Center for Retirement Research, offers three ways to shore up the system: raise taxes to bolster Social Security, make workplace retirement plans available to all workers, and encourage many Americans to work longer.

The bear market sell-off worsened on fears that the Fed will trigger a recession to control inflation. Yields hit highs. Oil prices tumbled.

BMO Capital analyst David Gagliano lowered the price target on United States Steel Corp (NYSE: X) to $23 (an upside of 15.5%) from $30 while maintaining the Market Perform rating on the shares. X provided its 'mid-quarter' update yesterday and mentioned that it expects 2Q22 EBITDA of $1.6 billion, vs. BMO/FactSet consensus of $1.5 billion. Related: United States Steel Stock Gains On Strong Q2 Outlook The analyst states that this update has no major surprises, considering other better-than-expect

Plus, a newcomer rolled out an artificial intelligence-based ETF.

The Bitcoin carnage continues, as the cryptocurrency breaks $20,000 to trade at its lowest level since 2020.

Earlier in the day, the bank's policy board decided to maintain ultralow interest rates, moving against a global trend of monetary tightening amid inflation.

(Reuters) -European stocks edged higher on Friday, but posted their third straight week of losses as a slew of interest rate hikes from major central banks fuelled worries about a sharp economic slowdown. The pan-European STOXX 600 index rose 0.1% in volatile trade, but ended the week 4.6% lower. World stock markets were heading for their biggest weekly decline since a pandemic-induced meltdown in March 2020, hit by growing worries about a recession after rate increases in the United States and Britain were followed by a surprise move in Switzerland to quell an inflation surge.

GPU prices are falling as crypto miners dump their now unprofitable rigs. That’s good news for gamers hoping to upgrade.

Some of the largest U.S. tampon makers are beefing up production to boost supplies as consumers in some parts say they cannot find their preferred products. The most prominent player with 60% of the market, Procter & Gamble Co (NYSE: PG), said it is running plants non-stop to ensure stores have an adequate supply. Edgewell Personal Care Co (NYSE: EPC) also reported production problems in the past year. Kimberly Clark Corp (NYSE: KMB), the third-largest tampon maker, said it had not experienced a

(Bloomberg) -- Sign up for the New Economy Daily newsletter, follow us @economics and subscribe to our podcast.Most Read from BloombergPutin Gets Unexpected Pushback From Ally Over War in UkraineChina Says It May Have Detected Signals From Alien CivilizationsSergey Brin Seeks Divorce, Joining Gates and Bezos in SplitMusk, Tesla, SpaceX Are Sued for Alleged Dogecoin Pyramid SchemeMonkeypox Testing Shows the US Learned Little From the Covid-19 PandemicThe European Central Bank intends to ensure th

The gold markets had initially fallen during the trading week, to reach down to the previous uptrend line. At this point, buyers came in to attempt to save the market.

Buffett swapped out Wells Fargo and Goldman Sachs for a beaten-down bank.

The asset management industry has inviting prospects and battered shares. Why BlackRock, T. Rowe Price, and others are worth a look.

Gas prices are at a record high nationwide, but there are a few things consumers can to ease the pain at the pump.